Engineering Chameleon Prodrug Nanovesicles to Increase Antigen Presentation and Inhibit PD‐L1 Expression for Circumventing Immune Resistance of Cancer
2021 · Advanced Materials · 63 citations
https://doi.org/10.1002/adma.202102668
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
11
Papers
443
Citations
8
h-index
8
i10-index
Zhifeng Zou is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Protein Degradation and Inhibitors & Nanoplatforms for cancer theranostics & Ubiquitin and proteasome pathways. The author has an h-index of 8, co-authored 10 publications.
Click to start Chat